Home > Journals > Esperienze Dermatologiche > Past Issues > Esperienze Dermatologiche 2021 March;23(1) > Esperienze Dermatologiche 2021 March;23(1):1-6

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Share

 

ORIGINAL ARTICLE   

Esperienze Dermatologiche 2021 March;23(1):1-6

DOI: 10.23736/S1128-9155.21.00513-6

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English, Italian

Treatment of xanthelasma with fractional plasma

Dorina CHELES

Department of Ophthalmology, The Baruch Padeh Medical Center, Poriya, Israel


PDF


BACKGROUND: Xanthelasma, which is a benign asymptomatic periorbital xanthoma, is not associated with cutaneous complications and treatment is often due to cosmetic reasons. Xanthelasma, which are depositions of yellowish cholesterol-rich material, and are associated with hyperlipidemia, or congenital disorder of lipid metabolism. Treatment modalities should be considered based on efficacy as well as cosmetic outcomes. There are different treatment modalities including: 1) surgical excision; 2) laser energy-based devices ablation; 3) topical therapy or systemic therapy; and 4) plasma-based device.
METHODS: The safety, patient satisfaction and cosmetic results of removal of xanthelasma with plasma-based device (Plasmage, Brera Medical Technologies S.r.l.; Ogliastro Cilento, Salerno, Italy) were shown in 50 patients after clinical evaluation.
RESULTS: All 50 cases of xanthelasmas were removed in our study with plasma-based device, Plasmage totally. No scars were left, and all patients were full satisfaction with almost no side effects, except local oedema and crusts which was solved quickly in few days.
CONCLUSIONS: The cosmetic outcome after removal of the xanthelasma with Plasmage, plasma-based device was excellent. The procedure of removal of xanthelasma with this plasma-energy device is safe, easy to perform, no scars, short downtime and very good patient satisfaction. This new noninvasive surgical device can be indicated also to other indications as therapy of dermatochalsis, removal of other facial or eyelids benign lesions as squamous papilloma and fibromas improving wrinkles and acne scars etc. More studies will be needed to confirm our results, but the clinical experience to date is excellent.


KEY WORDS: Dermatology; Xanthomatosis; Plasma

top of page